QUIDELORTHO CORP Increase (Decrease) in Income Taxes Payable
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Income Taxes Payable of $18.40 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in income taxes payable for the quarter ending 2026-06-28 was $5.40M, a 89.98% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for the quarter ending 2026-03-29 was $13.00M, a 261.11% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for the quarter ending 2025-12-28 was $10.50M, a 85.21% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for the quarter ending 2025-09-28 was -$26.30M.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for fiscal 2025 was $41.70M.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for fiscal 2024 was -$9.50M.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for fiscal 2023 was -$59.60M.
- QUIDELORTHO CORP increase (decrease) in income taxes payable for fiscal 2023 was -$26.80M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-28 | $5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $18.40M 10-Q · filed 2026-08-07 | $28.90M derived: sum of 3 quarters · filed 2026-08-07 | $2.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $13.00M 10-Q · filed 2026-05-06 | $23.50M derived: sum of 2 quarters · filed 2026-05-06 | -$2.80M derived: sum of 3 quarters · filed 2026-05-06 | $51.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$15.80M derived: sum of 2 quarters · filed 2026-02-19 | $38.10M derived: sum of 3 quarters · filed 2026-08-07 | $41.70M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$26.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $27.60M derived: sum of 2 quarters · filed 2026-08-07 | $31.20M 10-Q · filed 2025-11-06 | $102.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $53.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $57.50M 10-Q · filed 2026-08-07 | $128.50M derived: sum of 3 quarters · filed 2026-08-07 | $106.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $3.60M 10-Q · filed 2026-05-06 | $74.60M derived: sum of 2 quarters · filed 2026-05-06 | $52.30M derived: sum of 3 quarters · filed 2026-05-06 | $21.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $48.70M derived: sum of 2 quarters · filed 2026-02-19 | $18.20M derived: sum of 3 quarters · filed 2026-02-19 | -$9.50M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$22.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$52.80M derived: sum of 2 quarters · filed 2025-11-06 | -$80.50M 10-Q · filed 2025-11-06 | -$88.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$30.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$58.20M 10-Q · filed 2025-08-06 | -$66.50M derived: sum of 3 quarters · filed 2026-02-19 | -$71.50M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$27.70M 10-Q · filed 2025-05-08 | -$36.00M derived: sum of 2 quarters · filed 2026-02-19 | -$41.00M derived: sum of 3 quarters · filed 2026-02-19 | -$54.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$13.30M derived: sum of 2 quarters · filed 2026-02-19 | -$26.90M derived: sum of 3 quarters · filed 2026-02-19 | -$59.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$18.60M derived: sum of 2 quarters · filed 2024-11-08 | -$51.30M 10-Q · filed 2024-11-08 | -$68.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$13.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$46.30M 10-Q · filed 2024-08-01 | -$63.90M derived: sum of 3 quarters · filed 2025-02-27 | -$74.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$32.70M 10-Q · filed 2024-05-09 | -$50.30M derived: sum of 2 quarters · filed 2025-02-27 | -$61.10M derived: sum of 3 quarters · filed 2025-02-27 | -$197.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$28.40M derived: sum of 2 quarters · filed 2025-02-27 | -$165.20M derived: sum of 3 quarters · filed 2025-02-27 | -$26.80M 10-K · filed 2025-02-27 |
| 2022-10-02 | -$10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$147.60M derived: sum of 2 quarters · filed 2023-11-02 | -$9.20M 10-Q · filed 2023-11-02 | -$8.20M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$136.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.60M 10-Q · filed 2023-08-09 | $2.60M derived: sum of 3 quarters · filed 2024-08-01 | $60.90M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $138.40M 10-Q · filed 2023-05-04 | $139.40M derived: sum of 2 quarters · filed 2024-08-01 | $197.70M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $1.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $59.30M derived: sum of 2 quarters · filed 2024-08-01 | -$66.70M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $58.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$67.70M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | -$126.00M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $137.70M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |